Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. (COLL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · COLL · as of Jun 8, 2026
Key Statistics
Explore Collegium Pharmaceutical, Inc. Data
coll stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 66.7%
The COLL analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $58.00, representing +74.41% upside from the current price of $33.26.
Competitors & Peers
coll competitorsCOLL
AMPH
ATAI
CRON
DVAX
GDRXStock Performance
Full HistoryAbout Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, …
what is collegium pharmaceutical, inc. · coll stock overview · collegium pharmaceutical, inc. company profile · who is collegium pharmaceutical, inc. ceo · coll NASDAQ · collegium pharmaceutical, inc. headquarters · collegium pharmaceutical, inc. business segments
About Stock Overview & Key Data
Collegium Pharmaceutical, Inc. (COLL) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since May 7, 2015. As of the latest trading session, COLL stock price is $33.26, with a market capitalization of $1.1B. The stock has returned +9.25% over the past 12 months and -28.17% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Collegium Pharmaceutical, Inc. stock is Buy, with an average 12-month price target of $58.00. In fiscal year 2025, Collegium Pharmaceutical, Inc. reported revenue of $780.6M and net income of $62.9M. For detailed data — including Collegium Pharmaceutical, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Collegium Pharmaceutical, Inc. (COLL) stock price is $33.26. The stock is traded on NASDAQ under the ticker symbol COLL. The 52-week range is $29.08 – $50.79.